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Rift Valley Fever is an important zoonotic viral disease of livestock occurring across much
of Africa causing acute febrile illness, abortion, and neonatal death in livestock particularly
sheep and cattle and a range of disease in humans from mild flu-like symptoms to
more severe haemorrhagic fever and death. Understanding the epidemiology requires
well-evaluated tools including antibody detection ELISAs. It is well-recognized that
tests developed in one population do not necessarily perform as well when used in
different populations and it is therefore important to assess tests in the populations
in which they are to be used. Here we describe the performance of a commercial
RVF ELISA (ID.Vet) and an in-house plaque reduction neutralization test (PRNT80).
A Bayesian no gold standard latent class model for two tests and ≥2 populations
based on the Hui-Walter model was used to estimate the test parameters using a
range of populations based on geographical separation and age to assess consistency
of performance across different sub-populations. The ID.Vet ELISA had an estimated
diagnostic sensitivity (Se) of 0.854 (0.655–0.991 95%BCI) and specificity (Sp) of 0.986
(0.971–0.998 95%BCI) using all the data and splitting the population by geographical
region compared to 0.844 (0.660–0.973 95%BCI) and 0.981 (0.965–0.996 95%BCI)
for the PRNT80. There was slight variation in the mean Se and Sp in different
sub-populations mainly in Se estimates due to small numbers of positives in the
sub-populations but the 95% BCI generally overlapped suggesting a very consistent
performance across the different geographical areas and ages of animals. This is
one of few reports of serological evidence of RVF in Central Africa and strongly
suggests the virus is actively circulating in this cattle population. This has important
public health implications and RVF should be considered as a differential in both
livestock disease cases as well as human febrile cases in West and Central Africa
not just East Africa. We also demonstrate that the performance of the commercial
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ELISA is comparable to the PRNT80 but has the advantages of speed, lower cost and
no containment needs making it a much more useful test for low and middle income
settings (LMICs).
Keywords: Cameroon, no gold standard, sensitivity, specificity, Rift Valley fever (RVF)
INTRODUCTION
Rift Valley Fever (RVF) is amosquito-borne zoonotic viral disease
of ruminants, caused by a Phlebovirus in the Bunyaviridae family.
It was first described in Kenya in 1931, and has since been
reported in many African countries, as well as the Arabian
Peninsula (1–3). It is considered one of the most important
emerging zoonotic pathogens of public health significance
affecting mainly African communities with low resilience to
economic and environmental challenges (4). The epidemiology
is characterized by explosive epidemics in both humans and
livestock populations usually associated with flooding or dam
construction and long inter-epidemic periods where there is
little evidence of viral presence in those populations affected
by epidemics. Where the virus persists in these inter-epidemic
periods is still a major gap in our understanding of the
epidemiology of RVF (4).
Aedes and Culex mosquitoes are the main vectors of the RVF
virus (RVFV), and it can be transferred vertically from female
mosquitoes to their eggs in some species of the Aedes genera
(5–7). Sheep, goats, and cattle are the domestic species most
affected but clinical signs are usually mild and inapparent in
adult animals but can lead to major outbreaks of abortions and
death in neonates during epidemic periods which result in direct
significant economic losses (5, 8, 9). The disease can also affect
other wild animals such as buffalo, as well as spill over into
humans (10). RVF is transmitted between animals and to humans
through the bite of an infected mosquito vector. The disease
in humans can also result from direct contact with infected
tissues, blood or body fluids (11). A rise in RVFV prevalence
in domestic ruminants can sometimes precede epidemics in
humans (1) and similarly a decline in herd immunity in the
inter-epidemic periods coupled with extensive flooding appears
to facilitate these explosive outbreaks. Symptoms of the disease in
humans can vary, ranging from flu-like symptoms to more severe
conditions such as meningoencephalitis, haemorrhagic fever, or
death (5, 11). The case fatality rate for patients developing the
haemorrhagic form of the disease can be as high as 50% (4).
Epidemiological studies have focused upon East Africa (12)
where the virus was first isolated, with less known about
its significance in Central-West African human or livestock
populations although outbreaks in human populations in West
Africa have been associated with dam projects (4). Within the
Central African region, livestock and human cases of RVF
have been reported in the savanna of northern Cameroon,
Chad, and within forest areas in the Central African Republic.
Livestock seroprevalences of 9–20% within goat herds of
northern Cameroon (1, 13) and 4.4% in cattle, 10.7% in sheep
and 8.6% in goats in Chad (14) have been reported.Most recently,
in a large sample across Cameroon prevalence estimates of 13.5%
(11.4–15.7) for cattle and 3.4% (2.3–4.7) for small ruminants were
produced (15).
Cameroon is a significant cattle producer of the Central-
African region with livestock contributing ∼$476 million to the
national economy in 2010 (16) and being of cultural importance
to rural communities. The Northwest Region (NWR) and the
Vina Division (VD) of the Adamawa Region of Cameroon are
major cattle keeping areas in the wider Adamawa Plateau of
Central Africa. Cattle are kept for many reasons, including
financial, draft power, dairy products, and trade. The area is
mostly covered by sparse tree savannah, with a dry season
between November and April, and the wet season from May
until October (17). Culex spp. and Aedes spp. mosquitos are
present in Cameroon and due to the close association between
cattle and people in Cameroon, cattle may act as a reservoir
for RVF although little is known about its epidemiology in this
setting (15).
A number of tests have been developed to detect IgM and
IgG antibodies in different species including a new commercial
multi-species ELISA from ID.Vet (Montpellier, France) (15) and
an in-house plaque reduction neutralization test by the Canadian
(18). There are currently no validation studies in African cattle
populations. It is well-recognized that diagnostic tests developed
and validated in one population behave differently when used
in different settings (19, 20). This is important for surveillance
activities or risk factor evaluation in order for estimates at the
population level to be correctly adjusted for the test imperfections
and reliable estimates generated for evidence based decision
making. Using population based serum banks from studies in
Cameroon we are able to estimate test performance in naturally
infected populations with a range of coinfections that may
impact performance and thus get more reliable point estimates
as well as capturing the variation and thus the uncertainty of
these estimates.
Hui and Walter (21) developed a no gold standard model to
estimate test sensitivity and specificity in the absence of a gold
standard test under certain assumptions. These assumptions are
that each test performs the same in each population, that the
tests are conditionally independent (i.e., if a sample is positive
in one test this does not influence the probability it will be
positive on the other test conditional on its true status) and that
the prevalences are different in each of the sampled populations
(or the problem can become mathematically non-identifiable).
Applying the model in a Bayesian framework and making some
adjustment for the possible conditional dependence between tests
(22) allows us to estimate the test parameters (sensitivity and
specificity) as well as the population prevalence.
The aims of this study were to estimate the test performance
of two RVF diagnostic tests in a naturally infected population and
to assess the stability of these estimates in different geographical
Frontiers in Veterinary Science | www.frontiersin.org 2 August 2019 | Volume 6 | Article 258
Bronsvoort et al. RVF Test Evaluation
regions and age groups. In particular we were interested in
understanding how the ID.Vet test performed as it has wide
potential use as a simpler screening serological test for low
and middle income settings (LMICs). Secondly to describe the
seroprevalence of RVF exposures in cattle in the NWR and VD of
Cameroon in 2013.
MATERIALS AND METHODS
In reporting this analysis the authors have followed the STARD
(23) and recent STARD-BLCM (24) guidelines for reporting
diagnostic test accuracy.
Study Sites
The study was conducted in two sites in the NWR and VD
of the Adamawa Region of Cameroon. Both are of similar
geographical size of ∼17,000 km2. The NWR is situated in
the fertile mountainous highlands, 500–3,000m above sea level.
Bamenda, the capital, is Cameroon’s third largest city. The Region
is densely populated (1,804,695 people) and an estimated 506,548
cattle are grazed there (25). The VD is part of the fertile Adamawa
Region’s savannah plateau. The regional capital is Ngaoundere
and the population of the VD (317,888 people) is much smaller
than that of the NWR. The cattle population is also smaller
with an estimated 176,257 head (26). Veterinary services are
predominately provided by the government through theMinistry
of Livestock, Fisheries, and Industrial Agriculture/Ministere
de l’Elevage des Peches et Industries Animales (MINEPIA),
with local veterinary technicians stationed at Zootechnical and
Veterinary Sanitary Control Centers (ZVSCC) distributed across
the country (17). Their responsibilities include registration of
local livestock keepers, disease control mainly through annual
vaccination campaigns, meat inspection, and regulation of
livestock markets and animal movements.
Study Design
A cross sectional survey was conducted between January–May
2013 in the NWR and September–November 2013 in the VD.
These were pastoralists whose herds were listed in theMinistry of
Livestock, Fisheries, and Animal Industries vaccination records
at 81 local veterinary centers in the NWR and 31 in the VD in
2012. A total of 5,053 pastoralist herds in the NWR and 1,927 in
the VD, with a range of 1–215 cattle per herd were included in
the sampling frame. The list of herds in each site was stratified by
administrative area; seven Divisions in the NWR and eight sub-
Divisions within the VD and a random sample of herds was taken
from each site proportional to the total number of herds listed in
each of the two sites. This survey was part of a larger study of
bovine tuberculosis and liver fluke and the sample size was based
on a clustered random sample of cattle assuming a cattle level
prevalence of ∼10%, a within herd variance of 0.15 and between
herd variance of 0.01, an average herd size of 70, a relative cost of
12:1 for herd:cattle and relative error of ±15% (Survey Toolbox;
AusVet) (27). This gave a target sample size of 15 cattle per herd
and 88 herds under the simplifying assumption of perfect test
performance. To allow for potential losses or drop out and to have
balanced samples from the two sites, we aimed for 50 herds in
each of the two sites in the NWR and VD. Within each herd the
15 samples were stratified to each of three age classes; <2 years
old (young), 2–5 years old (adult), and older than 5 years (old).
ID Screen® Rift Valley Fever Competition
Multi-Species ELISA
The competitive ELISA was performed according to the
instructions of the manufacturer and all the samples were run
once. In brief, 50 µl of sample diluted 1:1 with the supplied
kit buffer was added to each test well of the recombinant RVF
nucleoprotein precoated plate and incubated for 1 h at 37◦C.
The plate was washed and 100 µl of the supplied anti-RVF-NP
conjugate added and incubated for a further 30min at 21◦C
and washed. 100 µl of supplied substrate solution supplied was
added and incubated for a final 15min at 21◦C before adding
the stop solution. The plate was read at 450 nm. To control
the validity of each plate, the mean value of the two negative
controls (ODNC) was calculated and the plate was considered
valid when ODNC > 0.7. For a valid plate, the mean value of the
two positive controls divided by ODNC should be <0.3. For each
sample the competition percentage was calculated by dividing
(ODsample/ODNC)× 100. The manufacturers suggest if the value
was≤40% the sample was considered positive. A value>50%was
a considered a negative result and values in between 40 and 50%
indicated an inconclusive result.
RVF PRNT80
RVFV strain ZH501 (28) was propagated in a mosquito cell line
(C6/36, ATCC) as previously described (18). Briefly, C6/36 cells
were infected at a multiplicity of infection (MOI) of 0.1 and
maintained at 28◦C in a 1:1 mixture of EMEM (Wisent) and ESF-
921 (Expression Systems, Woodland, CA, USA) supplemented
with 2.5% FBS, 25mMHEPES and 1mM sodium pyruvate. Vero
E6 cells were used to determine the titers of RVFV as previously
described (18).
Neutralizing antibody response to RVFV was determined by
plaque reduction neutralization test (PRNT80) modified from a
previously described protocol (5). Serial 2-fold dilutions of serum
in DMEM were made starting from 1 in 40 to obtain duplicates
of 100 µl/well for each serum sample. One hundred microliter of
DMEM containing 100 PFU of RVFV was added to each serum
dilution, mixed, and incubated at 37◦C, 5%CO2, and 95% relative
humidity for 1 h. Two hundred microliter of the virus/serum
mixture was then transferred onto a 48-well plate containing
confluent Vero E6 cell monolayer and incubated for another
1 h. An overlay of 1.75% carboxymethylcellulose in DMEM
containing 0.3% BSA was then added to all wells and plates
incubated at 37◦C, 5% CO2, and 95% relative humidity. Assay
of negative and positive control sera as well as a back titration of
the virus was performed at the same time as the test sera. After 4–
5 days the cells were fixed with 10% formalin, stained with 0.5%
crystal violet and plaques counted. The reciprocal of the highest
serum dilution that prevented at least 80% CPE was taken as the
PRNT80 titer for that sample.
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FIGURE 1 | Bivariate plot of the raw continuous values from the PRNT80 and ID.Vet RVF tests. The points are colored by study site and jittered on the y axis.
Horizontal and vertical lines in dashed red were added to mark the various cut-off values used. Note that for the PRNT80 a positive result is greater than the cut-off
while for the ID.Vet ELISA is lower than the cut-off.
Data Analysis
Hui and Walter (21) introduced a latent class approach to the
evaluation of diagnostic tests in the absence of a “gold-standard.”
The Hui-Walter paradigm requires two (or more) tests evaluated
in two (or more) populations. This model assumes that: (i) the
prevalence of the disease is different within each population; (ii)
the tests have the same properties across populations; (iii) and the
tests must be conditionally independent given the disease status.
The Bayesian version of the Hui-Walter model (29) assumes
that for the ith subpopulation the counts (Oi) of the different
combinations of test results, +/+, +/–, –/+, and –/– for the two
tests, follow a multinomial distribution:
Oi|Sej, Spj, pi∼Multinominal(Pri, ni) for i = 1, 2, . . . , S and
j = 1, 2, . . . , T
where S is the number of subpopulations, T is the number of tests
and Pri is a vector of probabilities of observing the individual
combinations of test results. Conditioning on the (latent) disease
status, these probabilities can be specified using the sensitivity
(Se) and specificity (Sp) of the tests and the prevalence (p) in
subpopulations. As an example, for two tests the probability of
observing both tests positive in the ith subpopulation is given as:
Pr(T1+, T2+) = Se1Se2pi + (1− Sp1)(1− Sp2)(1− pi)
The other three probabilities for the remaining three test
scenarios may be similarly derived.
In a Bayesian analysis all parameters are given distributions.
Hence, prior distributions for the test properties and the
prevalences within the subpopulations must be specified. For
prevalences where no information was available the distributions
were modeled using a uniform distribution on the interval
between 0 and 1 with a beta(1,1) distribution. The Se and Sp
of the two tests were modeled using the priors Se1∼Beta(20,1)
and Sp1∼Beta(5,1) for the ID.Vet ELISA based on published
estimates of performance (30) and vaguer priors Se2∼Beta(5,2)
and Sp2∼Beta(10,2) were used for the RVF PRNT80. A
sensitivity analysis was done to confirm that the priors were
not overwhelming the posteriors and driving the estimates (see
Supplementary Material S3).
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FIGURE 2 | Bayesian posterior means and 95% BCI for the two tests and their covariances (covDn, covDp) and the 13 prevalences for the subpopulations using the
Hui-Walter NGS model allowing for conditional dependence between tests. The four test/cut-off combinations are presented together for comparison.
If the two tests cannot be reasonably assumed
to be independent then the Hui-Walter model
must be extended (19, 31) to account for the
covariance structure between the two tests as below:
Pr(T1+, T2+) = ((Se
∗
1Se2)+ covDp)
∗pi + (((1− Sp1)
∗(1− Sp2))+ covDn)
∗(1− pi)
Pr(T1+, T2−) = (((Se1)
∗(1− Se2))− covDp)
∗pi + (((1− Sp1)
∗Sp2)− covDn)
∗(1− pi)
Pr(T1−, T2+) = ((1− Se1)
∗Se2)− covDp)
∗pi + ((Sp1
∗(1− Sp2))− covDn)
∗(1− pi)
Pr(T1−, T2−) = ((1− Se1)
∗(1− Se2)+ covDp)
∗pi + ((Sp
∗
1Sp2)+ covDn)
∗(1− pi)
The covDp and the covDn are the covariances between the two
tests when the animal is diseased and when it is not diseased,
respectively. The covariance between the test outcomes for
infected subpopulations satisfies (Se1-1)
∗(1-Se2)≤covDp≤
(min(Se1,Se2)-(Se1Se2)) and for the non-infected
subpopulation, (Sp1-1)
∗(1-Sp2)≤covDp≤ (min(Sp1,Sp2)-
(Sp1Sp2). Therefore, for instance, a uniform ((Se1-1)(1-Se2),
(min(Se1,Se2)-(Se1Se2))) prior distribution can be used
for covDp.
The model was implemented in JAGS using R (32) (code
available in Supplementary Material S1). For this analysis the
chains were used and the first 50,000 iterations were discarded
as a burn-in. A further 250,000 iterations were run for each chain
and then thinned by 100 to produce a set of 7,500 interactions
kept for posterior inference. The parameter estimates are the
mean of the posterior and the 0.025 and 0.975 quantiles
were used to give the Bayesian credibility intervals (BCI).
Convergence of the chain after the initial burn-in was assessed
by visual inspection of the time-series plots for the parameters,
as well as Gelman-Rubin statistic and diagnostic plots of model
convergence based on the three sample chains with dispersed
starting values (33).
Descriptive Statistics and Mapping
All statistical modeling and data visualization was conducted in
R 3.5.2 (34).
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RESULTS
A total of 1,498 cattle were sampled across the 2 study sites
(January–May 2013 in the NWR and September-November 2013
in the VD). Eighteen samples failed the PRNT80 test and a further
seven failed the ID.Vet test due to excessive hemolysis leaving
a final sample size of 1,473 for the remaining analyses. The raw
continuous readings from the two tests are presented in Figure 1
and there is generally good agreement.
An initial NGS analysis was conducted comparing the four
different combinations of tests/cut-offs to identify the best
TABLE 1 | No gold standard estimates of the sensitivity (Se) and specificity (Sp)
and Bayesian 95% credibility intervals (BCI) for the ID.Vet Rift Valley Fever ELISA at
a cut-off of 40 and the in house PRNT80 with a cut-off of 80.
Parameter Mean 95% BCI
Se IDVet ELISA 0.854 0.655–0.991
Sp IDVet ELISA 0.986 0.971–0.998
Se PRNT80 0.844 0.660–0.973
Sp PRNT80 0.981 0.965–0.996
combination for the rest of the analysis. The data was subset into
13 different populations based on the administrative Divisions
(NWR) or sub-Divisions (VD) used in the sampling design.
The posterior estimates for the test parameters and the different
population prevalences are shown in Figure 2. From this the
specificities are all very high with narrow 95% BCIs but as might
be expected using the lower cut-off for the PRNT80 in particular
results in lowered specificities. The sensitivities are all lower than
the specificities and have a much higher uncertainty around
the estimates reflecting the relatively small number of positives
in the sample (for all cut-offs used). Interestingly, all sets of
four prevalence estimates for each population are very consistent
across the test combinations. Overall the combination with the
ELISA cut-off set at 40pp or lower and the PRNT80 at 80 or
greater were considered the optimal cut-offs as they produced on
average the highest sensitivity and specificity estimates for both
tests (Table 1).
The Hui-Walter model assumes that the test performs the
same in each population. To explore this we repeated the
analysis at a site level running independent models for the
NWR and VD. The resulting estimates are given in Figure 3
and show that although these is some variation between the
FIGURE 3 | Bayesian mean and 95% BCI for the ID.Vet ELISA (cut-off 40pp) and the PRNT80 (cut-off 80) estimated independently in the two study sites in the
Northwest Region and Vina Division.
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FIGURE 4 | Map showing the two study sites in the Northwest Region and the Vina Division of Cameroon. The smaller chloropeth maps show the mean estimated
prevalence of rift valley fever seroprevalence for each site by Division (NWR) or sub-Division (VD).
sites the specificities remain very high and the sensitivities a
little lower with considerable uncertainty as might be expected
from the smaller sample sizes but overall a very similar estimate
across the two study sites. The prevalence estimates are almost
identical to those from the single model estates shown in
Figure 1. These have also been plotted on a map in Figure 4
to highlight the spatial variation in seroprevalence across
the two sites.
Finally, we were interested to compare the performance of the
tests in different age groups. The cattle were classified as young
(<2 years old), adult (≥2 but <5 years old), and old (≥5 years
old) based on the age and or dentition collected at the time of
the sampling. The estimates based on the two tests and 13 sub-
populations run as a single model are given in Figure 5 with
the test parameters further highlighted in Table 2. Again both
tests appear to perform very consistently across the different age
groups although the specificity seems to drop slightly in the old
class for both tests for reasons that are not clear but which are
reflected in higher levels of misclassification/lower agreement in
this age class. It is also reassuring that seroprevalence generally
increases with age group as one would expect for a vector borne
infectious disease (Figures 5 and 6).
DISCUSSION
Rift Valley fever is an important emerging zoonotic disease
in sub-Saharan Africa whose epidemiology is still poorly
understood and there is a need to evaluate low cost surveillance
tools for LMIC settings such as Cameroon. Here we have
compared 2 RVF diagnostic tests, an in-house PRNT and a
commercial ELISA (ID.Vet) using a latent class approach in a
Bayesian framework to deal with the problem of having no gold
standard test. The analysis first compared the tests using two
different cut-offs and identified the optimal combination of cut-
offs for the two tests that were then used for the remainder of
the analyses (Supplementary Table S2). We also then compared
their performances in geographically separated populations and
also across age groups to assess consistency of performance and
parameter estimates across these different groups. The results
suggest that the tests perform consistently across the different
groups with precise estimates of very high specificities and good
sensitivities but with more uncertainty in these. There is some
variation across the different subpopulation analyses, particularly
in sensitivity estimates. This may be due to the relatively small
numbers of positive animals per administrative area which results
in stochastic noise when the sample is sub-setted by site and age.
The model assumes that the tests perform the same in the
different populations and the results support this when the
sample was split and analyzed separately for each site (Figure 3).
We have included conditional dependence since both tests are
serology based as suggested by Toft et al. (29). In addition, Toft
et al. (29) warn about the potential inflation of the standard
errors when the difference between the prevalences in the
different subpopulations are small. In this study the range of
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FIGURE 5 | Bayesian mean and 95% BCI parameter estimates for the ID.Vet RVF ELISA (cut-off 40pp) and the RVF PRNT80 (cut-off 80) estimated independently in
the three age classes of cattle in Cameroon and the age class specific seroprevalence estimates across the 13 subpopulations.
TABLE 2 | No gold standard estimates of the sensitivity (Se) and specificity (Sp)
with Bayesian 95% credibility intervals (BCI) for the ID.Vet Rift Valley Fever ELISA
at a cut-off of 40 and the in house PRNT80 with a cut-off of 80 estimated
separately for each age group.
Parameter Age class Mean 95% BCI
Se ID.Vet ELISA Young 0.906 0.712–0.997
Adult 0.941 0.817–0.998
Old 0.857 0.655–0.992
Sp ID.Vet ELISA Young 0.992 0.977–1.000
Adult 0.990 0.973–1.000
Old 0.979 0.944–0.999
Se PRNT80 Young 0.786 0.577–0.956
Adult 0.754 0.567–0.937
Old 0.847 0.672–0.968
Sp PRNT80 Young 0.985 0.970–0.996
Adult 0.985 0.971–0.995
Old 0.958 0.920–0.989
prevalences is fairly wide therefore this should not be an issue.
Finally, the model assumes all individuals are independent and
does not account for clustering by herd which may lead to
underestimation of the standard error and narrower BCIs. The
specificity estimates are similar to those previously published
for both the ID.Vet RVF ELISA (0.997) (30) and PRNT80
(0.960) (35). The estimates for the sensitivity of the ID.Vet RVF
ELISA are lower than those published by Paweska et al. (30)
who report a sensitivity of 0.963. Our results suggest that in
this population it may perform less well but may be a better
reflection of performance in a naturally infected population
where we do not know the stage of infection and their is a
wider range of infectious doses. Other ELISA tests are available
including another competitive ELISA produced by Veterinary
Medicine Research and Development (Washington State) which
when compared to the PRNT80 had similar sensitivities and
specificities (36).
This represents the first report of estimating the ID.Vet
RVF ELISA performance in an African cattle population and
the ELISA shows great potential as a low cost easy to use
surveillance tool with very good overall accuracy comparable to
the more standardized PRNT80. Although generally considered
the reference test and widely used in reference laboratories
the PRNT80 is labor-intensive, time consuming, expensive, and
requires virus appropriate biocontainment (36) and so it not
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FIGURE 6 | Chloropeth maps showing the two study sites of the Northwest (Divisions) and Vina Division (sub-Divisions) of Cameroon and the Bayesian NGS mean
seroprevalence estimates for the three age classes from young adult and old.
practical for most surveillance activities particularly in LMICs.
Laboratories with only very basic equipment can use the kit
making it very appropriate for use in Africa.
Previous studies have demonstrated that RVF virus is
circulating in Cameroon and the Central African region more
widely. Further, the results presented in this paper suggest that
the seroprevalence of RVF in cattle varies across the study sites
between 2 and 12% with the exception of Ngoketunjia in the
NWR where it was particularly high at near 20%. This Division is
to the south of the Region and includes a large dam and swamp
areas where cattle are grazed and it would be consistent with
much higher vector populations. There is also a clear pattern of
increasing seroprevalence with age across the 13 sub-populations
over the two sites consistent with viral circulation although no
clinical disease has been reported. This may be because at the
time of the study there was no animal surveillance for abortions.
These estimates appear consistent with those recently reported
from Cameroon for the Adamawa Region in 2018 (15) and 1995
(13). They do not report seroprevalences in cattle for the NWR.
From discussions with local health personnel there is also very
limited diagnostic exploration of human febrile illnesses which
may lead into cases being missed. Given that there appears to
be viral circulation, screening of high risk human groups such as
slaughterhouse workers or veterinarians for evidence of exposure
should be prioritized to provide further evidence for the need
to include screening for RVF in febrile cases. Furthermore, RVF
outbreaks have been associated with dam construction in West
Africa and El Nino events in East Africa and changes in habitat
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that favor mosquito populations are a potential risk for triggering
epidemics (37). Interestingly the highest seroprevalence in this
study was from Ngoketunjia which includes a dam. With new
dams currently under construction in Cameroon the potential
risks for RVF outbreaks should be considered.
In conclusion we have demonstrated that both the ID.Vet
ELISA and PRNT80 have comparable performances in cattle from
Cameroon. This supports the use of the ELISA as a relatively low
cost easy to use surveillance tool for the African context. The
results also suggest that RVF virus is endemic and circulating in
Cameroonian cattle and it is interesting that no clinical reports
exist for cattle or humans. The results here and from other
studies in Cameroon suggest that human screening of febriles
illnesses should be considered by hospitals where malaria has
been ruled out.
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